Abstract
1. Twelve years' experience with 539 cases of erythroblastosis fetalis has been reviewed. 2. It is not possible to show beyond the statistical limits of chance that any change in mortality of erythroblastosis fetalis in relation to therapy in live born infants has occurred in this time. 3. It is probable that the early induction of labor has caused an increased risk to live born babies during part of this period, when erythroblastosis fetalis has been complicated by immaturity, particularly before 38 weeks' gestation. 4. Caution is urged in assaying the value of any therapeutic measure, the use of which in erythroblastosis fetalis may result in a selected body of clinical material.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
